Description

Science 2.0 uses the resources of Web 2.0 to communicate between scientists, and with the general public. Web 3.0, in turn, has brought disruptive technologies such as semantic search, cloud computing and mobile applications into play. The term Pharma 3.0 anticipates the future relationship between drug makers and doctors with their patients in light of such technology. From Science 2.0 to Pharma 3.0 examines these developments, discussing the best and worst of Web 2.0 in science communication and health. Successes such as the Open Access phenomena and also less successful networks are covered. This title is divided into three parts. The first part considers the Web 2.0 revolution, and the promise of its impact on science communication and the state of Science 2.0. The second part looks at impact on Pharma and Health, including attempts to utilise digital in Pharma. The last part looks at the promising disruptive technologies of Web 3.0, including semantic search in biomedicine and enterprise platforms. The book concludes by looking forward to developments of ‘3.0’ in Pharma and STM publishing.

Key Features

  • Gives a global overview of success and failure in Science 2.0
  • Presents useful stories and lessons learned
  • Gives a clear view of how semantic search is present in science platforms and its potential in STM publishing

Readership

Those interested in Science 2.0 and Pharma 3.0., including researchers, information professionals, and managers

Table of Contents

List of figures

List of abbreviations

Acknowledgements

About the authors

Introduction

Part 1: From Science 2.0 (2000–2010) …

Introduction

Chapter 1: The Web 2.0 revolution and the promise of Science 2.0

Abstract:

The web as a platform: web services, the cloud and the app

Harnessing collective intelligence

Data as the ‘next Intel Inside’

Chapter 2: The state of Science 2.0

Abstract:

A reluctance to change

Scepticism about the promise of Science 2.0

The lack of a supportive environment

Conclusion

Part 2: … and Pharma 2.0 …

Introduction

Chapter 3: Health 2.0 and beyond

Abstract:

2.0 becomes social media

Big promises: is there a pot of gold?

Leading Health 2.0 and social media sites and applications

Chapter 4: The digital pharma industry

Abstract:

The pharma industry adopts …

The pharma industry watches …

The pharma industry remains cautious: the dark face of SoMe

Part 3: … to Pharma 3.0 (2010–)

Introduction

Chapter 5: The semantic search in life sciences

Abstract:

Semantic? What’s this?

What do researchers expect?

A survey of biomedical semantic interfaces

The future will be semantic

The semantic for pharmas

Chapter 6: Enterprise 2.0 and Web 3.0

Abstract:

Enterprise 2.0

MS SharePoint 2010

And the next revolutions are?

Conclusion

Chapter 7: The next 3.0

Abstract:

Science 3.0

Pharma 3.0

Big STM 3.0

Conclusion

References

Index

Details

No. of pages:
286
Language:
English
Copyright:
© 2012
Published:
Imprint:
Chandos Publishing
Electronic ISBN:
9781780633756
Print ISBN:
9781843347095

About the authors

Hervé Basset

Hervé Basset is Librarian at a large pharmaceutical company. In parallel, he is an independent consultant and the owner of scienceintelligence.wordpress.com and regularly gives courses to information professionals and conferences. Hervé's current interest focuses on monitoring technologies and the application of Web 2.0 and Social Media to Science business. Hervé has a Masters degree in Library and Information Science.

David Stuart

David Stuart is a research associate at King's College London, and an honorary research fellow at the University of Wolverhampton where he previously completed his PhD in webometrics. He regularly writes about social media, open science, and the web of data in both academic and professional journals.

Denise Silber

Denise Silber is a trans-Atlantic eHealth pioneer, based in Paris and founder of the BASIL strategies agency and its well-known Doctors 2.0 TM & You, international healthcare social media conference. Denise applies Social media to the improvement of healthcare, and holds an MBA from Harvard.

Reviews

"In this work the authors highlight the added potential of cloud computing and publishing in an evolving and dynamic context. Success stories, as well as problems experienced, are shared. Although focusing on the pharmaceutical industry, the wider context of science, technology and medicine (STM) also features."--Online Information Review, Vol. 37 No. 6, 2013

I can only highly recommend reading this book by Hervé Basset for a better understanding of the challenges of social media., Jean-Philippe Accart
I was impressed by the team of authors who worked on the book. Their knowledge of the subject and understanding of the respective industries, as well as the level of control of vast literature and information is very impressive., Information Research
As a librarian in a large pharmaceutical company, Hervé Bassett has a perspective both on drug manufacturers and consumers of scientific information., Information Today